No profile data available.
HCW Biologics Inc. (HCWB) is a healthcare company in the medication development research industry, based in Miramar, United States, with about 35 full-time employees.
It reported revenue of $54,232 for fiscal year 2025, down 97.9% from fiscal year 2024, and net income of -$22.30 million. In Q2 2026 (the quarter ended June 30, 2026) revenue was $135,568, up 1969.7% from a year before. Its market capitalization was $3.58 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
, a clinical-stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and diseases in the United States.
HCW Biologics reported $54,232 in revenue for fiscal year 2025, down 97.9% from $2.57 million in fiscal year 2024. In Q2 2026 revenue was $135,568.
$3.58 million as of October 9, 2026.
Listed companies of a similar size in the same industry (medication development research) include Caribou Biosciences, Inc. (CRBU), iBio, Inc. (IBIO), Ernexa Therapeutics Inc. (ERNA), Vaccinex, Inc. (VCNX).